Filing Details
- Accession Number:
- 0001104659-24-067356
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-31 21:36:00
- Reporting Period:
- 2024-05-30
- Accepted Time:
- 2024-05-31 21:36:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1722964 | Y-Mabs Therapeutics Inc. | YMAB | Pharmaceutical Preparations (2834) | 474619612 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1752940 | Bo Kruse | C/O Y-Mabs Therapeutics, Inc. 230 Park Avenue, Suite 3350 New York NY 10169 | Evp, Cfo, Secry & Treas. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-30 | 28,629 | $2.00 | 239,506 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-30 | 28,629 | $12.03 | 210,877 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-05-31 | 31,371 | $2.00 | 242,248 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-31 | 31,371 | $12.07 | 210,877 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-05-30 | 28,629 | $0.00 | 28,629 | $2.00 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-05-31 | 31,371 | $0.00 | 31,371 | $2.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 271,371 | 2025-06-10 | No | 4 | M | Direct | |
| 240,000 | 2025-06-10 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $11.85 to $12.22, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $11.87 to $12.42, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- All of these stock options are currently vested.
Billionaire Hedge Funds
